Discounted Cash Flow Rating

Sell

Return on Equity Rating

Neutral

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Retractable Technologies, Inc (RVP)

Surgical & Medical Instruments & Apparatus

https://www.retractable.com

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to its other products.

511 LOBO LANE
LITTLE ELM, TX

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/04/2001

Market Cap

29,338,456

Shares Outstanding

29,940,000

Weighted SO

29,937,159

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

MLSS --.--%

PRTS --.--%

OCX --.--%

APT --.--%

INFU --.--%

Beta

2.0770

Last Div

0.0000

Range

0.87-1.34

Chg

-0.0200

Avg Vol

107441

Mkt Cap

29338456

Exch

AMEX

Country

US

Phone

972 294 1010

DCF Diff

1.0369

DCF

-0.0540

Div Yield

0.0000

P/S

0.6563

EV Multiple

-5.0630

P/FV

0.3434

Div Yield %

0.0000

P/E

-1.6419

PEG

-0.0713

Payout

-0.0130

Current Ratio

9.5069

Quick Ratio

6.5407

Cash Ratio

0.9232

DSO

38.2961

DIO

328.5421

Op Cycle

366.8382

DPO

46.4661

CCC

320.3721

Gross Margin

0.4528

Op Margin

-0.2788

Pretax Margin

-0.2389

Net Margin

-0.3997

Eff Tax Rate

-0.6735

ROA

-0.1112

ROE

-0.1862

ROCE

-0.0813

NI/EBT

1.6735

EBT/EBIT

0.8567

EBIT/Rev

-0.2788

Debt Ratio

0.0086

D/E

0.0163

LT Debt/Cap

0.0124

Total Debt/Cap

0.0160

Int Coverage

-171.1871

CF/Debt

5.5257

Equity Multi

1.8814

Rec Turnover

9.5310

Pay Turnover

7.8552

Inv Turnover

1.1110

FA Turnover

0.4964

Asset Turnover

0.2781

OCF/Share

0.2563

FCF/Share

0.2388

Cash/Share

0.2289

OCF/Sales

0.1716

FCF/OCF

0.9318

CF Coverage

5.5257

ST Coverage

24.1285

CapEx Coverage

14.6707

Div&CapEx Cov

10.1701

P/BV

0.3434

P/B

0.3434

P/S

0.6563

P/E

-1.6419

P/FCF

4.1035

P/OCF

3.8238

P/CF

3.8238

PEG

-0.0713

P/S

0.6563

EV Multiple

-5.0630

P/FV

0.3434

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 16, 22:18 Reviva Announces Proposed Public Offering Benzinga Oct 30, 13:49 Analyst Assessment On Reviva Pharmaceuticals' Positive Schizophrenia Trial Data - Sees More Than 200% Upside In Stock

Revenue Product Segmentation